A randomized, multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib in comparison with standard induction chemotherapy in elderly (>55 years) patients with Ph positive acute lymphoblastic leukemia (ALL)

Trial Profile

A randomized, multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib in comparison with standard induction chemotherapy in elderly (>55 years) patients with Ph positive acute lymphoblastic leukemia (ALL)

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Imatinib (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Dexamethasone; Idarubicin; Methotrexate; Vincristine
  • Indications Acute lymphoblastic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Apr 2007 Status changed to completed.
    • 22 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top